NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates

SAN DIEGO, Nov. 6 /PRNewswire-FirstCall/ — NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today the appointment of Michael J. Lambert as Executive Vice President and Chief Financial Officer, effective November 9, 2009. The Company also announced several other Executive Management Team updates.

“Michael will be an excellent complement to the NuVasive family,” said Alex Lukianov, Chairman and Chief Executive Officer of NuVasive. “He has proven himself to be a strong financial leader, including experience as the Chief Financial Officer of a medical device company with over $1 billion in revenue. Michael’s background has afforded him a wealth of experience in information technology and operations, which will be extremely valuable as we evolve into a much larger, yet still dynamic growth company.”

Mr. Lambert has been the Chief Financial Officer and held other key financial positions at other public companies. Most recently he was the Chief Financial Officer of Advanced Medical Optics, a medical device company focused on technologies used by eye care professionals. As the financial leader of a global organization, he developed in-depth operational expertise and critical analytical skills.

Mr. Lambert will succeed Kevin O’Boyle, who has served as the Chief Financial Officer of NuVasive since the company went public in 2004. Mr. O’Boyle will actively assist Mr. Lambert’s transition into his new role through the end of the year.

NuVasive continues to strategically evolve its organizational structure in anticipation of becoming a worldwide leader in innovative spine surgery. Central to the creation of NuVasive’s global infrastructure is a leadership team capable of driving the Company toward its long-term financial and strategic goals. To that end, NuVasive also announced the following management updates, each effective January 1, 2010:

* Patrick Miles will be promoted to President of the Americas, and will report to Keith Valentine, President and Chief Operating Officer. Mr. Miles will oversee NuVasive’s global creative product portfolio including marketing and development, clinical research, surgeon education, and sales for the Americas. Since 2001, Mr. Miles has devoted considerable energy and vision to leading the development and marketing efforts that have helped make NuVasive the unique and results-oriented spine company it is today.

* Jeffrey Rydin will be promoted to Executive Vice President of Sales, Americas. Mr. Rydin will assume direct sales responsibility for the entire Americas’ sales force. He also will serve as Chairman of our newly formed Global Sales Executive Committee designed to ensure that NuVasive’s global sales and marketing strategy is carried out to maximize results. Mr. Rydin has made enormous contributions to our top line growth since joining NuVasive from Johnson & Johnson four years ago.

* Jason Hannon will be promoted to Executive Vice President and General Counsel. Mr. Hannon will continue to be responsible for strategic planning, business development, and legal. His role will expand to include government affairs and broader administrative influence. Since joining NuVasive from private practice, Mr. Hannon has successfully taken on increasing responsibility and operational influence.

NuVasive is focused on expanding internationally and has added Executive Vice Presidents for both Asia and Europe that will report to Keith Valentine, President and Chief Operating Officer:

* Takaaki Tanaka has been appointed Executive Vice President of Asia Pacific. Mr. Tanaka will drive sales and strategic business initiatives in the Asia Pacific region, working from Tokyo, Japan. Mr. Tanaka joins NuVasive with a track-record of success in driving revenue and market share gains in the Asia Pacific region, having led the Medtronic Spinal, Biologics and Navigation Divisions to the #1 market share spot for the Asia Pacific region. He brings to NuVasive a wealth of experience in dealing with the unique dynamics of the Asia Pacific region.

* Stephan Siemers has been appointed Executive Vice President of Europe. Mr. Siemers will spearhead NuVasive’s European sales and operations effort from Bremen, Germany. Stephan joins NuVasive following over fifteen years with Johnson & Johnson, where he most recently served as President of their international spine division. During his tenure, Mr. Siemers successfully reorganized the German sales and marketing structure, and was responsible for Europe, Middle East, Africa, Asia Pacific, Latin America, and Canada. His division enjoyed the largest and most consistent sales growth for the entire organization.

Alex Lukianov, Chairman and Chief Executive Officer, said, “As we increase focus on becoming the #4 global spine company and growing to a $1 billion spine franchise, we need a strong management team with the ambition and experience to drive the growth of operations and exemplify NuVasive’s culture of Absolute Responsiveness and product innovation. I am excited to announce these additions to the depth and strategic composition of our senior management team. I look forward to working with this well-qualified leadership team to achieve our goals at Cheetah Speed.”


Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button